AI assistant
RECCE PHARMACEUTICALS LTD — Director's Dealing 2017
Jan 15, 2017
65669_rns_2017-01-15_30c70270-a2a4-49ca-b049-1801ea79b400.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Recce Ltd |
|---|---|
| ABN | 73 124 849 065 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Graham John Hamilton Melrose |
|---|---|
| Date of last notice | 15 July 2016 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| n eNote: Ibe discl | n eNote: Ibe discl | case of a rus, s ncues neress n en the case of a company, interests which come witosed in this part. | rus mae avaae yhin paragraph (i) of the de | rus mae avaae yhin paragraph (i) of the de | e response eny of e rusfinition of “notifiable interest of a director” sh | e response eny of e rusfinition of “notifiable interest of a director” sh | ould | ould |
|---|---|---|---|---|---|---|---|---|
| Dir | ||||||||
| Dir | ect or indirect interest | Di | ||||||
| rec | t | |||||||
| Na(inNot | ture of indirect interestcluding registered holder)e: Provide details of the circumstances ivin rise | |||||||
| Not a | pplicable | |||||||
| to the relevant | ||||||||
| gginterest. | ||||||||
| Date of change | 16 January 2017 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No of securities held prior | No of securities held prior | ||||||
|---|---|---|---|---|---|---|---|
| No of securities held prior | to change | 14720 | 3 ordinar sh | ares* | |||
| . | ,,27,843,months | y960 ordinary sfrom 15/1/20 | hares* (escro16) | wed for 24 | |||
| 1,059,0fl | 00 Class A Pel id di | rformance Shh | ares* (andid | ||||
| any uconversi15/1/20 | y pa oron) (escrowe16) | nary saresd for 24 m | ssue ononths from | ||||
| 6,075,0any ful | 00 Class B Pely paid ordi | rformance Shnary shares | ares* (andissued on | ||||
| conversi15/1/20 | on) (escrowe16) | d for 24 m | onths from | ||||
| 6,075,0any ful | 00 Class C Pely paid ordi | rformance Shnary shares | ares* (andissued on | ||||
| conversi15/1/20 | on) (escrowe16) | d for 24 m | onths from | ||||
| Class | Fully paid ordinary shares | ||||||
| Number acquired | 1,059,000 | ||||||
| Number disposed | Nil | ||||||
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Nil consideration | ||||||
| No. of securities held after change | 1,472,043 ordinary shares*28,902,960 ordinary shares* (escrowed for 24months from 15/1/2016)6,075,000 Class B Performance Shares* (andany fully paid ordinary shares issued onconversion) (escrowed for 24 months from15/1/2016)6,075,000 Class C Performance Shares* (andany fully paid ordinary shares issued onconversion) (escrowed for 24 months from15/1/2016)6,075,000 Class D Performance Shares* (andany fully paid ordinary shares issued onconversion) (escrowed for 24 months from15/1/2016)*held jointly with spouse Olga Mary Melrose |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back | Conversion of Class A Performance Shares uponachievement of the milestone, i.e. the volumeweighted average price of shares as traded on ASXover 20 consecutive trading days on which theshares are traded is not less than $0.30. |
|---|
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | Not applicable |
|---|---|
| Nature of interest | Not applicable |
| Name of registered holder(if issued securities) | Not applicable |
| Date of change | Not applicable |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | Not applicable |
| Interest acquired | Not applicable |
| Interest disposed | Not applicable |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | Not applicable |
| Interest after change | Not applicable |
Part 3 –[+] Closed period
| art 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required? | No |
| If so, was prior written clearance provided to allow the trade toproceed during this period? | Not applicable |
| If prior written clearance was provided, on what date was thisprovided? | Not applicable |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3